Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More 05/17/13 Boston
Atlas Leans on Amgen, Novartis to Build New Startups 05/16/13 Boston
Radius Health CEO: Skin Patch Data is the Value Driver 05/13/13 Boston
NW Biotech Education Group Faces Loss of Federal Money, Deep Cuts 05/02/13 Seattle
Bind Therapeutics, AstraZeneca Collaborate on Cancer Drug 04/22/13 Boston
From Assets to Zen: Building Successful Drug Hunting Relationships 04/22/13 San Diego
East Coast Life Sciences Roundup: Optimer, Bind, Pfizer, and More 04/05/13 Boston
Bind Therapeutics Reels Pfizer into Nanomedicine Partnership 04/03/13 Boston
Gilead Sciences Building on HIV, Becoming Cancer Drug Force 04/01/13 National
AstraZeneca Shells Out $240M Upfront For Moderna mRNA Drugs 03/21/13 Boston
Affymax Cuts 230 Jobs, Mulls Bankruptcy, After Drug Withdrawal 03/18/13 San Francisco
Has The Pendulum Swung Too Far in Favor of Rare Diseases? 03/14/13 Seattle
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
East Coast Life Sciences Roundup: Merck, Celgene, PTC, Cerulean 03/08/13 Boston
Roger Perlmutter Returns to Merck, Looks to Biotech Future (Again) 03/07/13 New York
Corporate Compliance Programs: The Importance of Being Effective 02/15/13 National
Ironwood Bucks the Trends, Makes Big Bet on Drug For Millions 02/06/13 Boston
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug 02/04/13 Boston
Keryx Finally Succeeds With a Clinical Trial, for Kidney Disease Drug 01/28/13 New York
Alder Biopharma Looks to Take On Migraines, and the World 01/24/13 Seattle
VenBio’s Goodman Builds an Inside Periscope on Biotech Acquisitions 01/23/13 San Francisco
The Intersection of the Double Helix and Life Sciences in Seattle 01/22/13 Seattle
Boston’s Got Big Mo in Biotech, But SF is Pushing Back 01/21/13 National
East Coast Life Sciences Roundup: Bind, Boston Children’s, J&J, More 01/11/13 Boston
Mid-Priced Biotechnology Companies Bloom As M&A Targets in 2013 01/10/13 San Francisco
BIND CEO Says Amgen Deal Marks Nanomedicine Turning Point 01/09/13 Boston
Amgen in $180.5 Million Drug Development Deal with BIND Biosciences 01/08/13 Boston
My Report Card for JP Morgan Healthcare Conference Picks 01/07/13 National
Crescendo Bioscience Snags $28M For Arthritis Test 01/03/13 San Francisco
East Coast Life Sciences Roundup: Ariad, Celgene, Amgen, More 12/14/12 Boston
Page 1 of 11 next page »